VEGFA and colorectal cancer: Fang et al. showed that miR-622 inhibits colorectal cancer tumorigenesis and metastasis by downregulating CXCR4, thereby reducing Vascular Endothelial Growth Factor A (VEGFA) and CD34, resulting in an antiangiogenic effect [55].